Maximo F. Nougues

CFO

Chief Financial Officer

Puma Biotechnology, Inc.

Insider activity · 24 months0 buys6 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 1 saleFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 2 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 2 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 1 saleAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (36 ops.)

€457k

Latest filing published 08 Jul 2026 for Puma Biotechnology, INC., €68k.

Filing timeline

BuySale

Maximo F. Nougues

Insider track record

Disclosed buys

Disclosed sells

Signal history

Maximo F. Nougues: trading record in brief

Maximo F. Nougues is a declared insider of Puma Biotechnology, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 43 filings cover trades dated from 11 February 2020 to 6 July 2026.

The open-market record consists of 36 sales worth €457k, with no purchase. Besides market trades, the filings include 7 share grants. 2026 to date brings no purchases and 3 sales.

Most recently, on 8 July 2026, the filings show an open-market sale worth €68k in Puma Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Maximo F. Nougues

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Puma Biotechnology, Inc. (US)

Declarations43 total

▼
Maximo F. Nougues
Chief Financial OfficerExecutives6 Jul 2026Puma Biotechnology, Inc.
77,557 USD43SEC
9,386 shares@ US$8.2630.016% mcap14.8% of flowCommon StockSEC:0001437749-26-023077:0
◆
Maximo F. Nougues
Chief Financial OfficerExecutives18 Feb 2026Puma Biotechnology, Inc.
0SEC
46,739 shares0Common StockSEC:0001437749-26-004946:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives7 Jan 2026Puma Biotechnology, Inc.
37,661 USD35SEC
6,405 shares@ US$5.886.1% of flowCommon StockSEC:0001437749-26-000921:1
▼
Maximo F. Nougues
Chief Financial OfficerExecutives6 Jan 2026Puma Biotechnology, Inc.
26,532 USD34SEC
4,540 shares@ US$5.8444.9% of flowCommon StockSEC:0001437749-26-000921:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives9 Jul 2025Puma Biotechnology, Inc.
13,930 USD37SEC
3,935 shares@ US$3.542.3% of flowCommon StockSEC:0001437749-25-022551:1
▼
Maximo F. Nougues
Chief Financial OfficerExecutives8 Jul 2025Puma Biotechnology, Inc.
19,739 USD37SEC
5,587 shares@ US$3.5333.7% of flowCommon StockSEC:0001437749-25-022551:0
◆
Maximo F. Nougues
Chief Financial OfficerExecutives7 Feb 2025Puma Biotechnology, Inc.
0SEC
61,456 shares0Common StockSEC:0001437749-25-003461:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Jan 2025Puma Biotechnology, Inc.
32,232 USD38SEC
10,227 shares@ US$3.15176.8% of flowCommon StockSEC:0001437749-25-000365:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives17 Jul 2024Puma Biotechnology, Inc.
15,382 USD37SEC
4,156 shares@ US$3.70113.1% of flowCommon StockSEC:0001437749-24-023022:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Jul 2024Puma Biotechnology, Inc.
17,307 USD37SEC
5,295 shares@ US$3.26853.5% of flowCommon StockSEC:0001437749-24-022067:0
◆
Maximo F. Nougues
Chief Financial OfficerExecutives12 Feb 2024Puma Biotechnology, Inc.
0SEC
43,307 shares0Common StockSEC:0001437749-24-004216:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives3 Jan 2024Puma Biotechnology, Inc.
70,348 USD38SEC
15,682 shares@ US$4.485914.0% of flowCommon StockSEC:0001437749-24-000768:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives3 Jul 2023Puma Biotechnology, Inc.
48,608 USD38SEC
14,680 shares@ US$3.31129.7% of flowCommon StockSEC:0001437749-23-019525:0
◆
Maximo F. Nougues
Chief Financial OfficerExecutives10 Feb 2023Puma Biotechnology, Inc.
0SEC
58,601 shares0Common StockSEC:0001437749-23-003382:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives3 Jan 2023Puma Biotechnology, Inc.
43,864 USD38SEC
10,499 shares@ US$4.17799.0% of flowCommon StockSEC:0001437749-23-000547:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Dec 2022Puma Biotechnology, Inc.
715 USD37SEC
159 shares@ US$4.49780.1% of flowCommon StockSEC:0001437749-22-028558:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Nov 2022Puma Biotechnology, Inc.
367 USD34SEC
163 shares@ US$2.250.1% of flowCommon StockSEC:0001437749-22-026032:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives3 Oct 2022Puma Biotechnology, Inc.
385 USD34SEC
165 shares@ US$2.33540.1% of flowCommon StockSEC:0001437749-22-023679:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Sept 2022Puma Biotechnology, Inc.
425 USD37SEC
164 shares@ US$2.58960.1% of flowCommon StockSEC:0001437749-22-021986:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives5 Jul 2022Puma Biotechnology, Inc.
24,547 USD38SEC
9,328 shares@ US$2.63155.2% of flowCommon StockSEC:0001437749-22-018991:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Aug 2022Puma Biotechnology, Inc.
465 USD37SEC
161 shares@ US$2.890.1% of flowCommon StockSEC:0001437749-22-018993:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives5 Jul 2022Puma Biotechnology, Inc.
15,355 USD37SEC
5,835 shares@ US$2.63153.3% of flowCommon StockSEC:0001437749-22-016850:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives2 Jun 2022Puma Biotechnology, Inc.
311 USD37SEC
162 shares@ US$1.92180.1% of flowCommon StockSEC:0001437749-22-014434:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives3 May 2022Puma Biotechnology, Inc.
386 USD34SEC
165 shares@ US$2.34010.1% of flowCommon StockSEC:0001437749-22-010926:0
▼
Maximo F. Nougues
Chief Financial OfficerExecutives4 Apr 2022Puma Biotechnology, Inc.
634 USD37SEC
206 shares@ US$3.0780.1% of flowCommon StockSEC:0001437749-22-008328:0

25 of 43 declarations

Maximo F. Nougues

Insider track record

Maximo F. Nougues: trading record in brief

Companies and markets linked to Maximo F. Nougues

Similar companies

Related executives